Fig. 1From: E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathwayE2A expression correlates with progression-free survival of colorectal cancer. a E2A expression (upper panel) and Lgr5 expression (lower panel) in representative immunohistochemistry images. 200×. b Progression-free survival of patients with high and low E2A expression (P < 0.05). c Progression-free survival of patients with respective E2A and Lgr5 expression (P < 0.05)Back to article page